RS

Ravi Subbanna Chandakavadi

Active Director Director DIN 07984470
DIN 07984470 First appointment Nov 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2017
Shareholding value •••• Premium profile

About Ravi Subbanna Chandakavadi

Data last updated:

Ravi Subbanna Chandakavadi is a Director at Snig Pharma Private Limited (since 2017). The company operates in Pharma. Snig Pharma Private Limited reported revenue of ₹6.94 Cr (FY 2025).

DIN 07984470
Primary Designation Director
Industry Pharma
First Appointment 25 Nov 2017
Oldest Company Age 11 yrs
Largest company Snig Pharma Private Limited · ₹6.94 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Snig Pharma Private Limited U52590KA2015PTC082351
Director25 Nov 20172015₹6.94 Cr (FY 2025)Active

Board colleagues of Ravi Subbanna Chandakavadi

Directorship timeline

Open interactive timeline →
Snig Pharma Private Limited
Premium access

Shareholding and investment profile for Ravi Subbanna Chandakavadi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Subbanna Chandakavadi

Ravi Subbanna Chandakavadi currently holds 1 directorship: Snig Pharma Private Limited (Director, since 25 Nov 2017, revenue ₹6.94 Cr (FY 2025)).

Ravi Subbanna Chandakavadi was first appointed on 25 Nov 2017 as Director at Snig Pharma Private Limited.

The current boards of Ravi Subbanna Chandakavadi's companies include Davanagere Ravindra Santhosh (Snig Pharma Private Limited), Marilinge Gowda Vivekananda (Snig Pharma Private Limited), Poornima Patil (Snig Pharma Private Limited), Raghukumar Jogad (Snig Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available